Background: Candida auris is an unusual, emerging species which was first isolated from a patient with a discharge from the external ear canal. Isolation of clonal strains of C. auris from patients at different hospitals in Korea and India suggest that interand intra-hospital transmission of infection due to this species occurs. C. auris is closely related to Candida haemulonii and the Metschnikowiaceae clade. It has been mis-identified as C. haemulonii or Rhodotorula glunitis using Vitek 2 YST and API 20C AUX respectively. However, sequence analysis of the internal transcribed spacer (ITS) region and the D1/D2 domain of the large subunit ribosomal RNA gene facilitate accurate identification. C. auris has higher fluconazole minimum inhibitory concentrations (MICs) compared to other Candida species though echinocandins and amphotericin B have been reported to be more active. We report for the first time, C. auris as a causative agent of candidemia in South Africa.
Methods & Materials: Four isolates from patients with candidemia admitted to different hospitals in South Africa were analysed. These isolates were sent to National Institute for Communicable Diseases for identification to species-level. Identification was undertaken using ChromAgar Candida medium, Vitek 2 YST, API 20C Aux and sequencing of ITS and D1/D2 domains of the rRNA gene, followed by broth microdilution susceptibility testing for nine antifungal drugs.
Results: All four isolates were misidentified as Candida haemulonii and Rhodotorula glutinis using Vitek 2 YST and API 20C Aux assays respectively. Pairwise alignment of both ITS and D1/D2 domains using the CBS KNAW fungal diversity database showed 98%-99% sequence homology to Kuwaiti and Indian C. auris isolates. All isolates had high fluconazole minimum inhibitory concentrations. Amphotericin B and echinocandins had good activity against C. Background: Influenza-like illness (ILI) increases the number of annual visits to health care centers. However the description of health seeking behavior during the context of an influenza pandemic and posterior years is sparse of developing countries. This study compares the healthcare seeking behavior of individuals with ILI during 3 periods: (i) the pandemic (2009), (ii) the transition (2010), and (iii) the post-pandemic period (2011).
Methods & Materials:
We used data collected in a prospective active household ILI surveillance conducted in a shanty-town in Lima, Peru. ILI events and health seeking behavior were characterized trough a questionnaire during household visits 3 times/week. Healthcare seeking behavior is defined as the intent of seeking medical (i.e. health post, clinic or hospital) or non-medical (i.e. pharmacy, traditional healer) attention. Multivariable logistic regression models were applied to determine the association of gender, age, education of the household head, insurance, and influenza laboratory results with health seeking behavior. We randomly selected a single ILI event per each of 321 households enrolled in the main cohort.
Results: Overall, we found that 191 of 321 participants (59.5%, 95%CI 54.1-64.7) sought any kind of healthcare (61.3% in 2009, 60.2% in 2010 and 56.1% in 2011, p=0.75) and 124 of them (64.9%, 95%CI 57.9-71.3) sought non-medical care. We observed that 86.3% (107/124, 95%CI 79.1-91.3) of people who sought non-medical attention went to pharmacies to obtain medication without prescription. We found no differences among pandemic and non pandemic years regarding people who sought medical and nonmedical attention (p=0.64). In 2009 and 2010, individuals 18 to 49 years old were less likely to seek medical care compared to children less than 5 years (adjusted OR 0.08 95%CI 0.009-0.59 and OR 0.02 95%CI 0.003-0.19, respectively).
Conclusion: Even though higher numbers of medical visits were reported during the pandemic period in Spain and France, we found no variation in medical health seeking behavior between pandemic and non-pandemic years. This could be attributed to cultural factors, some characteristics of primary care centers and accessibility to pharmacies in Peru. http://dx.doi.org/10.1016/j.ijid.2014.03.870
